Skip to main content

Table 3 Clinical features of three patients who achieved triple response

From: Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection

Number age (years)/sex genotype Pretreatment HBV titer (log copies/mL) Pretreatment HBsAg titer (IU/ml) HBeAg Dose of PEG-IFN (μg) Duration of PEG-IFN treatment (weeks) Pretreatment AST/ALT (IU/ml)
1 26/male C 7.6 4470 positive 180 48 47/123
2 30/female C 5.3 1000 positive 90 48 45/62
3 34/male A 7.6 881 positive 90 48 37/397